Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: The GLORIA-AF Registry, phase II

American Journal of Medicine

Volumn 128, Issue 12, 2015, Pages 1306-1313.e1

  Huisman, Menno V ^a   Rothman, Kenneth J ^b   Paquette, Miney ^c   Teutsch, Christine ^d   Diener, Hans Christoph ^e   Dubner, Sergio J ^f   Halperin, Jonathan L ^g   Ma, Changsheng ^h   Zint, Kristina ^d   Elsaesser, Amelie ^d   Bartels, Dorothee B ^d   Lip, Gregory Y H ⁱ  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RTI HEALTH SOLUTIONS   (United States)

^c BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f Clinica y Maternidad Suizo Argentina   (Argentina)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h CAPITAL MEDICAL UNIVERSITY   (China)

ⁱ UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Anticoagulation; Atrial fibrillation; Registry; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; DABIGATRAN; FIBRINOLYTIC AGENT; VITAMIN K GROUP;

ADULT; AGED; ANTICOAGULANT THERAPY; ASIA; ATRIAL FIBRILLATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE REGISTRY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONVALVULAR ATRIAL FIBRILLATION; NORTH AMERICA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VISUAL ANALOG SCALE; ANTAGONISTS AND INHIBITORS; CLINICAL PRACTICE; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; STATISTICS AND NUMERICAL DATA; STROKE; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; DABIGATRAN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PROSPECTIVE STUDIES; REGISTRIES; STROKE; TREATMENT OUTCOME; VITAMIN K;

EID: 84947867490     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.07.013     Document Type: Conference Paper

References (22)

1. R.G. Hart, L.A. Pearce, and M.I. Aguilar Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 146 12 2007 857 867
2. R. De Caterina, S. Husted, L. Wallentin, and et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease Thromb Haemost 110 6 2013 1087 1107
3. V. Sjogren, B. Grzymala-Lubanski, H. Renlund, and et al. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula Thromb Haemost 113 6 2015 1370 1377
4. P. Gallego, V. Roldan, F. Marin, and et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation Thromb Haemost 110 6 2013 1189 1198
5. A.J. Camm, G.Y. Lip, R. De Caterina, and et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 10 2012 1385 1413
6. J.Y. Le Heuzey, B. Ammentorp, H. Darius, and et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF Registry Thromb Haemost 111 5 2014 833 841
7. T. Wilke, A. Groth, S. Mueller, and et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients Thromb Haemost 107 6 2012 1053 1065
8. M.V. Huisman, G.Y. Lip, H.C. Diener, and et al. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation Am Heart J 167 3 2014 329 334
9. G.Y. Lip, R. Nieuwlaat, R. Pisters, and et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2 2010 263 272
10. R. Pisters, D.A. Lane, R. Nieuwlaat, and et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 5 2010 1093 1100
11. R. Nieuwlaat, A. Capucci, G.Y. Lip, and et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 24 2006 3018 3026
12. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 23 2014 2071 2104
13. C.E. Chiang, K.L. Wang, and G.Y. Lip Stroke prevention in atrial fibrillation: an Asian perspective Thromb Haemost 111 5 2014 789 797
14. A.Y. Shen, J.F. Yao, S.S. Brar, and et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation J Am Coll Cardiol 50 4 2007 309 315
15. Y. Wan, C. Heneghan, R. Perera, and et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review Circ Cardiovasc Qual Outcomes 1 2 2008 84 91
16. G.Y. Lip, K. Wang, and C. Chiang Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: time for a reappraisal Int J Cardiol 180C 2015 246 254
17. G.Y. Lip The role of aspirin for stroke prevention in atrial fibrillation Nat Rev Cardiol 8 10 2011 602 606
18. C.W. Ho, M.H. Ho, P.H. Chan, and et al. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control Stroke 46 1 2015 23 30
19. T.S. Potpara, M.M. Polovina, J.M. Marinkovic, and G.Y. Lip A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study Int J Cardiol 168 5 2013 4744 4749
20. G. Boriani, C. Laroche, I. Diemberger, and et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry Am J Med 128 5 2015 509 518.e2
21. A.K. Kakkar, I. Mueller, J.P. Bassand, and et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry PLoS One 8 5 2013 e63479
22. G.Y. Lip, C. Laroche, G.A. Dan, and et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry Europace 16 3 2014 308 319